◆ TICKERBASEインタラクティブ表示 →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
ホーム › 全銘柄 › ABBOTINDIA · English version

Abbott India Limited (ABBOTINDIA)

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Healthcare · ウォール街（米国） · 最終更新: 2026-09-20

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products.

主要指標

インタラクティブチャートと全財務諸表を見る →

年次損益計算書

損益計算書2026-03-312025-03-312024-03-312023-03-31
売上高合計₹69.3B₹64.1B₹58.5B₹53.5B
売上総利益₹32.2B₹29.0B₹26.1B₹23.6B
営業利益（EBIT）₹18.2B₹16.4B₹14.1B₹11.5B
当期純利益₹15.5B₹14.1B₹12.0B₹9.5B

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は ABBOTINDIA のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/ABBOTINDIA

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.